Last reviewed · How we verify
NCT03099954
Withings Pulse Wave Velocity and Blood Pressure Study
trial in Elevated Blood Pressure in 300 participants. Completed in 31 October 2017.
1 August 2017
Quick facts
| Lead sponsor | Scripps Translational Science Institute |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 19 January 2017 |
| Primary completion | 1 August 2017 |
| Estimated completion | 31 October 2017 |
| Sites | 1 location across United States |
Conditions studied
- Elevated Blood Pressure — all drugs for Elevated Blood Pressure →
- Hypertension — all drugs for Hypertension →
- Mental Stress — all drugs for Mental Stress →
- Sleep Disorders — all drugs for Sleep Disorders →
Sponsor
Scripps Translational Science Institute
Who can join
18 and older, any sex, with Elevated Blood Pressure or Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Measure pulse wave velocity stability in relation to time of day, day of the week, physical activity, sleep quality, stress levels and blood pressure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03099954
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Elevated Blood Pressure
Currently open trials in the same condition.
- NCT07397754 — Sodium-rich COndiments Unifying Health and Taste · NA · recruiting
- NCT06348225 — Post-exercise Hot Water Immersion to Improve Overnight Blood Pressure · NA · recruiting
- NCT05469503 — Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure · NA · active not recruiting
- NCT05297708 — Office, Home, and Ambulatory Blood Pressure · active not recruiting
- NCT04766424 — Sleep Technology Intervention to Target Cardiometabolic Health · NA · active not recruiting
Other Scripps Translational Science Institute trials
Trials by the same sponsor.
- NCT06244940 — The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study · NA · recruiting
- NCT05741112 — The Long COVID-19 Wearable Device Study · NA · recruiting
- NCT05655546 — ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals · NA · terminated
- NCT05197738 — Research Framework Exploring Sleep Health · recruiting
- NCT04881019 — PRediction Of Glycemic RESponse Study · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03099954 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Scripps Translational Science Institute
- Last refreshed: 1 March 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03099954.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing